Nalbutin

Nalbutin10 mg/ml

IM/IV Injection


By
MRP 100.305% Off
Best PriceTk /
Out Of Stock
1
Section

Medicine overview

Indications of Nalbutin 10 mg/ml

for preoperative and postoperative analgesiaand for obstetrical analgesia during labor and delivery.

Theropeutic Class

Opioid analgesics

Pharmacology

Nalbutin 10 mg/ml Hydrochloride is a synthetic potent analgesic.

Absorption

Its analgesic potency is essentially equivalent to that of morphine on a milligram basis.

Distribution

Receptor studies show that Nalbutin 10 mg/ml binds to mu, kappa, and delta receptors, but not to sigma receptors.

Metabolism

Nalbutin 10 mg/ml is primarily a kappa agonist/partial mu antagonist analgesic.

Dosage & Administration of Nalbutin 10 mg/ml

Notes:The usual recommended adult dose is 10 mg for a 70 kg individual, administered subcutaneously, intramuscularly or intravenously; this dose may be repeated every 3 to 6 hours as necessary. Dosage should be adjusted according to the severity of the pain, physical status of the patient, and other medications which the patient may bereceiving
Moderate to severe pain
Dosage:by intravenous or intramuscular injection 10-20 mg for 70 kg patient, adjusted as required; child up to 0.3 mg/kg repeated once or twice as necessary
Preoperative anesthesia
Dosage:by intravenous or intramuscular injection 0.1-0.2 mg/kg
Obstetrical analgesia during labor & delivery
Dosage:by intravenous injection 0.3-1 mg/kg over 10-15 minutes with maintenance doses of 0.25-0.5 mg/kg in single intravenous administration as required
Intraoperative analgesia
Dosage:by intravenous injection 0.25-0.5 mg/kg at 30 minutes intervals
Myocardial infarction
Dosage:By slow intravenous injection 10-20 mg, repeated after 30 minutes if necessary
Notes:Larger dose is required when used as supplement of anesthesia than that required for analgesia
Children from 18 months to 15 years old
Dosage:usually 0.2 mg/ kg body-weight, given preferably by intravenous or intramuscular injection
Notes:Maintenance doses may be given at intervals of 4 to 6 hours or the dose must be determined by the physician

Dosage of Nalbutin 10 mg/ml

Notes:The usual recommended adult dose is 10 mg for a 70 kg individual, administered subcutaneously, intramuscularly or intravenously; this dose may be repeated every 3 to 6 hours as necessary. Dosage should be adjusted according to the severity of the pain, physical status of the patient, and other medications which the patient may bereceiving
Moderate to severe pain
Dosage:by intravenous or intramuscular injection 10-20 mg for 70 kg patient, adjusted as required; child up to 0.3 mg/kg repeated once or twice as necessary
Preoperative anesthesia
Dosage:by intravenous or intramuscular injection 0.1-0.2 mg/kg
Obstetrical analgesia during labor & delivery
Dosage:by intravenous injection 0.3-1 mg/kg over 10-15 minutes with maintenance doses of 0.25-0.5 mg/kg in single intravenous administration as required
Intraoperative analgesia
Dosage:by intravenous injection 0.25-0.5 mg/kg at 30 minutes intervals
Myocardial infarction
Dosage:By slow intravenous injection 10-20 mg, repeated after 30 minutes if necessary
Notes:Larger dose is required when used as supplement of anesthesia than that required for analgesia
Children from 18 months to 15 years old
Dosage:usually 0.2 mg/ kg body-weight, given preferably by intravenous or intramuscular injection
Notes:Maintenance doses may be given at intervals of 4 to 6 hours or the dose must be determined by the physician

Interaction of Nalbutin 10 mg/ml

No hazardous interactions have been identified with Nalbutin 10 mg/ml; however, interactions described with other opioids may be anticipated. Patient receiving a narcotic analgesic, general anesthesia, phenothiazines or other tranquilizers, sedatives, hypnotics, or other CNS depressants (including alcohol) concomitantly with Nalbutin 10 mg/ml may exhibit an additive effect.

Contraindications

Known hypersensitivity to Nalbutin 10 mg/ml Hydrochloride.

Side Effects of Nalbutin 10 mg/ml

Generally Nalbutin 10 mg/ml is well tolerated. However few side-effects like sedation, sweating, nausea, vomiting, dizziness, vertigo, dry mouth, headache, respiratory depression, dyspnea and asthma may be seen.

Pregnancy & Lactation

Pregnancy category B. The placental transfer of Nalbutin 10 mg/ml is high and rapid. There are no well-controlled studies in pregnant women. This drug should be used during pregnancy only if clearly needed. Limited data suggest that Nalbutin 10 mg/ml is excreted in maternal milk but only in a small amount (less than 1% of the administered dose) and with a clinically insignificant effect. Caution should be exercised when Nalbutin 10 mg/ml is administered to a nursing woman.

Precautions & Warnings

Caution should be taken in the following conditions: impaired respiration, impaired renal or hepatic function, billiary tract surgery, myocardial infarction and hypotension.

Overdose Effects of Nalbutin 10 mg/ml

Sleepiness & mild dyspnea may occur due to overdose. The immediate intravenous administration of an opiate antagonist such as Naloxone or Nalmefene is a specific antidote. Oxygen, intravenous fluids, vasopressors and other supportive measures should be used as indicated

Storage Conditions

Keep it in a cool and dry place, protected from light and moisture.

Drug Classes

Opioid analgesics

Mode Of Action

Nalbutin 10 mg/ml Hydrochloride is a synthetic potent analgesic. Its analgesic potency is essentially equivalent to that of morphine on a milligram basis. Receptor studies show that Nalbutin 10 mg/ml binds to mu, kappa, and delta receptors, but not to sigma receptors. Nalbutin 10 mg/ml is primarily a kappa agonist/partial mu antagonist analgesic.

Pregnancy

Pregnancy category B. The placental transfer of Nalbutin 10 mg/ml is high and rapid. There are no well-controlled studies in pregnant women. This drug should be used during pregnancy only if clearly needed. Limited data suggest that Nalbutin 10 mg/ml is excreted in maternal milk but only in a small amount (less than 1% of the administered dose) and with a clinically insignificant effect. Caution should be exercised when Nalbutin 10 mg/ml is administered to a nursing woman.

Frequently Asked Questions

What is Nalbutin 10 mg/ml used for?

Nalbuphine Hydrochloride is indicated for the relief of moderate to severe pain. It is used for relief of moderate to severe pain associated with myocardial infarction (MI). Nalbuphine Hydrochloride can also be used as a supplement to balanced anesthesia, for preoperative and postoperative analgesia, and for obstetrical analgesia during labor and delivery.

What is the dosage of Nalbutin 10 mg/ml?

The usual recommended adult dose is 10 mg for a 70 kg individual, administered subcutaneously, intramuscularly or intravenously; this dose may be repeated every 3 to 6 hours as necessary. Dosage should be adjusted according to the severity of the pain, physical status of the patient, and other medications which the patient may bereceiving.Moderate to severe pain: by intravenous or intramuscular in…

What are the side effects of Nalbutin 10 mg/ml?

Generally Nalbuphine is well tolerated. However few side-effects like sedation, sweating, nausea, vomiting, dizziness, vertigo, dry mouth, headache, respiratory depression, dyspnea and asthma may be seen.

Who should not take Nalbutin 10 mg/ml?

Known hypersensitivity to Nalbuphine Hydrochloride.

What precautions should be taken with Nalbutin 10 mg/ml?

Caution should be taken in the following conditions: impaired respiration, impaired renal or hepatic function, billiary tract surgery, myocardial infarction and hypotension.

Is Nalbutin 10 mg/ml safe during pregnancy and breastfeeding?

Pregnancy category B. The placental transfer of Nalbuphine is high and rapid. There are no well-controlled studies in pregnant women. This drug should be used during pregnancy only if clearly needed. Limited data suggest that Nalbuphine is excreted in maternal milk but only in a small amount (less than 1% of the administered dose) and with a clinically insignificant effect. Caution should be exerc…

Disclaimer

The information provided is accurate to our best practices, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy. The absence of specific information about a drug should not be seen as an endorsement. We are not responsible for any consequences resulting from this information, so consult a healthcare professional for any concerns or questions.